Get 15% Off on World Health Day Flash Sale Get 15% Off on World Health Day Flash Sale


Researchers Work on Getting Intermittent Fasting FDA Approved as Adjunct Cancer Treatment to Improve Long-Term Survival Rates

Story at-a-glance -

  • Time-restricted eating has been shown to prevent and reverse obesity and related metabolic dysfunction
  • Fasting helps “starve” cancer cells, simultaneously protecting cells from chemotherapy toxicity. Researchers are now seeking FDA approval for intermittent fasting (IF) as an adjunct to augment cancer treatments
  • In a human pilot study, cycles of monthly five-day long calorie restriction decreased risk factors and biomarkers for aging, diabetes, cardiovascular disease, and cancer

By Dr. Mercola

Research published in the journal Cell Metabolism concluded that time-restricted eating not only prevented but also reversed obesity and related metabolic dysfunction.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access